Sava
PrivateLast Round
Series A
Jul 31, 2025
Est. Valuation
$32M
Total Funding Raised
$33.39M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sava is a healthtech company developing a wearable biosensor platform for real-time, multi-molecule health monitoring, with its first product being a continuous glucose monitor (CGM).
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, Healthcare Analytics, Vertical SaaS
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sava Comparables
Compare Sava with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Signos | 74% | |
| GlucoModicum | 74% | |
| GlucoRx | 71% |
Sava Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 31, 2025 | ||||
| Seed | Jun 21, 2024 | ||||
| Seed | Jun 1, 2020 | ||||
| Grant | Sep 1, 2019 |
Key People
Founding team and executive leadership
Sava Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| True | Series A |
| Solo Investments | Series A |
| Athletico Ventures | Series A |
| Solo Investments Holdings | Series A |
| Koinos Capital SGR | Series A |
| Exceptional Ventures | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 35% MoM, reaching 7.3K.
- Jun 24, 2026
Grew 15% QoQ, from 126 to 145 employees.
Recent news
Latest coverage and updates
- is_developingJul 9, 2026
SAVA Technologies Ltd. is developing biosensing technology to read health signals through the skin painlessly and in real time.
Sava Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sava's valuation, stock price, and market status.
Is Sava a public or private company?
Sava is a private company.
What is the current stock price of Sava?
Sava is a private company with no public stock price. No recent secondary market data is available.
How much is Sava worth (valuation)?
Valuation information for Sava is not publicly available.
Can I buy Sava stock?
Sava shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sava's last funding round?
Sava's most recent funding round was Series A on July 31, 2025.
Who are the main investors in Sava?
Key investors in Sava include Pentland Ventures, Balderton Capital, Exor Ventures.
Will Sava IPO soon?
No public IPO plans have been announced for Sava.
How can I track Sava secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sava's secondary market activity and sign up for updates.